LIMITED STAGE SMALL CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Pronged attack tested in aggressive lung cancer
Disease control Recruiting nowThis study is testing whether a new two-drug immunotherapy combination (BMS-986489) works better than the current standard immunotherapy (durvalumab) for people with limited-stage small cell lung cancer. About 250 participants who have already completed initial chemotherapy and r…
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: SCRI Development Innovations, LLC • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug trial aims to keep aggressive lung cancer at bay
Disease control Recruiting nowThis study is testing whether a drug called tarlatamab can help keep limited-stage small cell lung cancer from getting worse after initial treatment. It will enroll 37 patients who have already completed a specific type of chemo-radiotherapy but were not eligible for a more inten…
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Gut bacteria joins fight against aggressive lung cancer
Disease control Recruiting nowThis study is testing whether adding probiotics (beneficial bacteria) to a combination of high-dose radiation, chemotherapy, and an immunotherapy drug called adebrelimab can better control limited-stage small cell lung cancer. It will involve 60 patients to see if this approach h…
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for lung cancer patients: drug study aims to keep cancer at bay
Disease control Recruiting nowThis study is observing how well a drug called durvalumab works to help control limited stage small-cell lung cancer after patients finish standard chemoradiation treatment. It will follow 200 patients in China who have not gotten worse after their initial treatment. The goal is …
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for lung cancer patients: drug trial aims to stop Cancer's return
Disease control Recruiting nowThis study is testing whether a drug called tarlatamab can help people with a specific type of lung cancer stay in remission longer after their initial treatment. It will involve about 400 adults whose cancer has not gotten worse after standard chemotherapy and radiation. The mai…
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC